World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
18308
World Ranking
14172
National Ranking
5975

Overview

David Chia is affiliated with the University of California, Los Angeles in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on several subfields including Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, and Infectious Diseases.

The main topics addressed in Chia's work include Cancer Genomics and Diagnostics, Advanced Biosensing and Bioanalysis Techniques, Single-cell and Spatial Transcriptomics, Lung Cancer Treatments and Mutations, Salivary Gland Disorders and Functions, as well as SARS-CoV-2 and COVID-19 research and detection.

Chia's recent papers demonstrate an ongoing engagement with molecular diagnostics and cancer detection methodologies. Notable publications include:

  • The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring, 2023, published in Cell Reports Medicine
  • Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients, 2020, published in Cancers
  • Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA, 2022, published in iScience
  • Electric Field-Induced Release and Measurement (EFIRM), 2020, published in Journal of Molecular Diagnostics
  • Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma, 2021, published in Cancers

Frequent collaborators in Chia's research include David T. Wong, Jordan Cheng, Feng Li, Yong Kim, and Wei Fang.

Chia has published extensively in several scientific journals. The leading venues for their work are:

  • European Urology Open Science
  • Cancers
  • Biomarker Research
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  • Frontiers in Oncology

Best Publications

  • Mortality Results from a Randomized Prostate-Cancer Screening Trial

    Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys

  • Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

    Saundra S. Buys;Edward Partridge;Amanda Black;Christine C. Johnson

  • Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

    Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys

  • Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

    Philip C Prorok;Gerald L Andriole;Robert S. Bresalier;Saundra S Buys

  • α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

    Jorge A. Marrero;Ziding Feng;Yinghui Wang;Mindie H. Nguyen

  • Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.

    Melissa K. Tuck;Daniel W. Chan;David Chia;Andrew K. Godwin

  • Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

    James J Farrell;Lei Zhang;Hui Zhou;David Chia

  • Characterization of Sialosylated Lewisx as a New Tumor-associated Antigen

    Kiyoyasu Fukushima;Masaki Hirota;Paul I. Terasaki;Akemi Wakisaka

  • Global levels of histone modifications predict prognosis in different cancers.

    David B. Seligson;Steve Horvath;Matthew A. McBrian;Vei Mah

  • Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

    Saundra S. Buys;Edward Partridge;Mark H. Greene;Philip C. Prorok

  • Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.

    Lei Zhang;James J. Farrell;Hui Zhou;David Elashoff

  • Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma

    Harvey I. Pass;Stephen M. Levin;Michael R. Harbut;Jonathan Melamed

  • Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.

    Lei Zhang;Hua Xiao;Scott Karlan;Hui Zhou

  • Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings From the Initial Screening Round of a Randomized Trial

    Gerald L. Andriole;David L. Levin;E. David Crawford;Edward P. Gelmann

  • Role of Pancreatic Cancer-derived Exosomes in Salivary Biomarker Development

    Chang Lau;Yong Kim;David Chia;Nadine Spielmann

  • COX-2-dependent stabilization of survivin in non-small cell lung cancer

    Kostyantyn Krysan;Farrukh H. Merchant;Li Zhu;Mariam Dohadwala

  • A new microcellular cytotoxicity test based on calcein AM release.

    Xiu Ming Wang;Paul I. Terasaki;George W. Rankin;David Chia

  • Prevalidation of Salivary Biomarkers for Oral Cancer Detection

    David Elashoff;Hui Zhou;Jean Reiss;Jianghua Wang

  • MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.

    Candice Sun Hong;Nicholas A. Graham;Wen Gu;Carolina Espindola Camacho

  • Higher levels of GATA3 predict better survival in women with breast cancer

    Nam K. Yoon;Erin L. Maresh;Dejun Shen;Yahya Elshimali

Frequent Co-Authors

David T.W. Wong
David T.W. Wong University of California, Los Angeles
Steve Horvath
Steve Horvath University of California, Los Angeles
Paul I. Terasaki
Paul I. Terasaki University of California, Los Angeles
David Elashoff
David Elashoff University of California, Los Angeles
Paul F. Pinsky
Paul F. Pinsky National Institutes of Health
Barnett S. Kramer
Barnett S. Kramer National Institutes of Health
E. David Crawford
E. David Crawford University of California, San Diego
Steven M. Dubinett
Steven M. Dubinett University of California, Los Angeles
Edward P. Gelmann
Edward P. Gelmann University of Arizona
Gerald L. Andriole
Gerald L. Andriole Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re studying Biology or Biochemistry in the USA, you have access to a wide range of online degree options and rewarding career pathways in healthcare and medical technology. One rapidly growing field is health information management, which offers flexible learning through health information management schools online. These programs prepare you for roles that blend science, technology, and patient care.

Another popular pathway is medical billing and coding. The medical billing and coding outlook is quite positive, with rising demand for skilled professionals. Many students interested in these careers pursue credentials such as cpc certification, which can increase job prospects and earning potential.

Wondering about salaries? You can learn more about how much do medical coders make and find guidance on entering the field. With an online degree in a health-related discipline, you can open doors to essential roles that support patient care and healthcare systems nationwide.

Best Scientists Citing David Chia

Trending Scientists

Recently Published Articles